F.‐A. Wiesel

2.5k total citations
46 papers, 2.0k citations indexed

About

F.‐A. Wiesel is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, F.‐A. Wiesel has authored 46 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Psychiatry and Mental health, 13 papers in Cellular and Molecular Neuroscience and 10 papers in Molecular Biology. Recurrent topics in F.‐A. Wiesel's work include Schizophrenia research and treatment (13 papers), Treatment of Major Depression (8 papers) and Medical Imaging Techniques and Applications (7 papers). F.‐A. Wiesel is often cited by papers focused on Schizophrenia research and treatment (13 papers), Treatment of Major Depression (8 papers) and Medical Imaging Techniques and Applications (7 papers). F.‐A. Wiesel collaborates with scholars based in Sweden, Switzerland and Italy. F.‐A. Wiesel's co-authors include Göran Sedvall, Lars Farde, L. Bjerkenstedt, Gustav Wik, Kjell Fuxé, T. Greitz, G. Blomqvist, Gunnel Alfredsson, Lars Hagenfeldt and C. Härnryd and has published in prestigious journals such as Brain Research, Neuroscience and Journal of Neurochemistry.

In The Last Decade

F.‐A. Wiesel

46 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F.‐A. Wiesel Sweden 28 830 764 377 375 280 46 2.0k
David L. Garver United States 28 988 1.2× 591 0.8× 322 0.9× 430 1.1× 187 0.7× 82 2.3k
Burt Angrist United States 23 1.2k 1.4× 765 1.0× 464 1.2× 309 0.8× 132 0.5× 61 2.2k
Frits‐Axel Wiesel Sweden 27 1.1k 1.4× 1.1k 1.4× 297 0.8× 551 1.5× 128 0.5× 65 2.5k
Henrik Nybäck Sweden 25 592 0.7× 1.0k 1.3× 366 1.0× 713 1.9× 165 0.6× 53 2.1k
E. Zarifian France 26 749 0.9× 785 1.0× 308 0.8× 495 1.3× 105 0.4× 88 2.1k
Celeste A. Johns United States 21 1.5k 1.8× 433 0.6× 387 1.0× 252 0.7× 143 0.5× 34 2.5k
C H van Dyck United States 9 636 0.8× 968 1.3× 355 0.9× 446 1.2× 158 0.6× 12 2.1k
Burton Angrist United States 34 1.4k 1.7× 1.7k 2.2× 787 2.1× 594 1.6× 180 0.6× 62 3.2k
Peter A. Sargent United Kingdom 18 404 0.5× 1.0k 1.4× 442 1.2× 409 1.1× 359 1.3× 24 2.1k
Seiya Miyamoto Japan 21 816 1.0× 870 1.1× 323 0.9× 665 1.8× 107 0.4× 48 2.2k

Countries citing papers authored by F.‐A. Wiesel

Since Specialization
Citations

This map shows the geographic impact of F.‐A. Wiesel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.‐A. Wiesel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.‐A. Wiesel more than expected).

Fields of papers citing papers by F.‐A. Wiesel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.‐A. Wiesel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.‐A. Wiesel. The network helps show where F.‐A. Wiesel may publish in the future.

Co-authorship network of co-authors of F.‐A. Wiesel

This figure shows the co-authorship network connecting the top 25 collaborators of F.‐A. Wiesel. A scholar is included among the top collaborators of F.‐A. Wiesel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.‐A. Wiesel. F.‐A. Wiesel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nilsson, Björn M., et al.. (2010). Physical capacity, respiratory quotient and energy expenditure during exercise in male patients with schizophrenia compared with healthy controls. European Psychiatry. 27(3). 206–212. 14 indexed citations
2.
Bjerkenstedt, L., et al.. (2009). Aberrant amino acid transport in fibroblasts from patients with bipolar disorder. Neuroscience Letters. 457(1). 49–52. 16 indexed citations
3.
Nilsson, Björn M., Christina M. Hultman, & F.‐A. Wiesel. (2006). Niacin skin-flush response and electrodermal activity in patients with schizophrenia and healthy controls. Prostaglandins Leukotrienes and Essential Fatty Acids. 74(5). 339–346. 31 indexed citations
4.
Nilsson, Björn M., Anders Forslund, Roger Olsson, Leif Hambræus, & F.‐A. Wiesel. (2005). Differences in resting energy expenditure and body composition between patients with schizophrenia and healthy controls. Acta Psychiatrica Scandinavica. 114(1). 27–35. 28 indexed citations
5.
Sonnander, Karin, et al.. (2004). Needs assessed by psychiatric health care and social services in a defined cohort of clients with mental disabilities. European Archives of Psychiatry and Clinical Neuroscience. 255(1). 57–64. 9 indexed citations
6.
Wiesel, F.‐A., Gunnar Edman, Lena Flyckt, et al.. (2004). Kinetics of tyrosine transport and cognitive functioning in schizophrenia. Schizophrenia Research. 74(1). 81–89. 21 indexed citations
7.
Wiesel, F.‐A. & L. Bjerkenstedt. (1996). Tyrosine transport as an indicator of cell membrane dysfunction in schizophrenia. Prostaglandins Leukotrienes and Essential Fatty Acids. 55(1-2). 55–58. 3 indexed citations
8.
Karlsson, Per, Lars Farde, C. Härnryd, et al.. (1995). Lack of apparent antipsychotic effect of the D1-dopamine recepotr antagonist SCH39166 in acutely ill schizophrenic patients. Psychopharmacology. 121(3). 309–316. 114 indexed citations
9.
Johnson, Allan E., Ulla Liminga, Anders Lidén, et al.. (1994). Chronic treatment with a classical neuroleptic alters excitatory amino acid and GABAergic neurotransmission in specific regions of the rat brain. Neuroscience. 63(4). 1003–1020. 27 indexed citations
10.
Angst, Jules, Per Bech, J. Bruinvels, et al.. (1994). Report on the Fifth Consensus Conference: Methodology of Long-Term Clinical Trials in Psychiatry. Pharmacopsychiatry. 27(3). 101–107. 7 indexed citations
11.
Wiesel, F.‐A., Nikolaos Venizelos, L. Bjerkenstedt, & Lars Hagenfeldt. (1994). Tyrosine transport in schizophrenia. Schizophrenia Research. 13(3). 255–258. 17 indexed citations
12.
13.
Farde, Lars, F.‐A. Wiesel, Lars Nilsson, & G. Sedvall. (1989). The Potential of Positron-Emission Tomography for Pharmacokinetic and Pharmacodynamic Studies of Neuroleptics. PubMed. 7. 32–39. 2 indexed citations
14.
Farde, Lars, et al.. (1989). D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology. 99(S1). S28–S31. 252 indexed citations
15.
Wiesel, F.‐A., et al.. (1989). Clinical melperone treatment blocks D2‐dopamine receptors in the human brain as determined by PET. Acta Psychiatrica Scandinavica. 80(S352). 30–34. 5 indexed citations
16.
Wik, Gustav, Stefan Borg, I Sjögren, et al.. (1988). PET determination of regional cerebral glucose metabolism in alcohol‐dependent men and healthy controls using 11C‐glucose. Acta Psychiatrica Scandinavica. 78(2). 234–241. 60 indexed citations
17.
Sedvall, Göran, Lars Farde, H. Hall, et al.. (1988). PET Scanning — A New Tool in Clinical Psychopharmacology. PubMed. 5. 27–33. 7 indexed citations
18.
Farde, Lars, et al.. (1988). An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PET. Psychopharmacology. 94(1). 1–7. 94 indexed citations
19.
Wiesel, F.‐A., Gustav Wik, I Sjögren, G. Blomqvist, & T. Greitz. (1987). Altered relationships between metabolic rates of glucose in brain regions of schizophrenic patients. Acta Psychiatrica Scandinavica. 76(6). 642–647. 25 indexed citations
20.
Wiesel, F.‐A., Gustav Wik, I Sjögren, et al.. (1987). Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates. Acta Psychiatrica Scandinavica. 76(6). 628–641. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David L. Garver Breakdown of academic impact, for papers by Burt Angrist Breakdown of academic impact, for papers by Frits‐Axel Wiesel Breakdown of academic impact, for papers by Henrik Nybäck Breakdown of academic impact, for papers by E. Zarifian Breakdown of academic impact, for papers by Celeste A. Johns Breakdown of academic impact, for papers by C H van Dyck Breakdown of academic impact, for papers by Burton Angrist Breakdown of academic impact, for papers by Peter A. Sargent Breakdown of academic impact, for papers by Seiya Miyamoto
Rankless by CCL
2026